US Representative Johnson’s View on America Invents Act
shot by IP News Shots / 10:18 am on 12 May, 2021
US Representative, Hank Johnson, has expressed his view on the America Invents Act (AIA) by stating that the Congress needs to review the act. Interestingly, the Patent Trial and Appeal Board (PTAB) was instituted because of the AIA. The act is set to complete 10 years this September.
Read More at: https://news.bloomberglaw.com/ip-law/johnson-says-landmark-patent-law-due-for-comprehensive-evaluation
Industry: Others
China’s Patent Law Move Towards Enabling Innovation in Biotech
shot by IP News Shots / 5:03 pm on 04 May, 2021
China has worked on the revision of their Patent Law to make it more favorable for biotech innovation and for encouraging more foreign drugs to enter the market in the country. The revised law establishes a drug patent linkage system and compensates for lost patent terms, on the lines of the Hatch-Waxman Act in the US. The new version of the Patent Law is set to be put to action from the 1st of June, 2021.
Read More at: https://www.bioworld.com/articles/506664-china-overhauls-patent-law-to-stay-competitive-in-biotech-innovation?v=preview
Industry: Biotechnology
The US Senate Judiciary Committee Passes IDEA Act
shot by IP News Shots / 3:57 pm on 30 April, 2021
The Inventor Diversity for Economic Advancement (IDEA) Act has been passed by the full Senate Judiciary Committee. The act is aimed at directing the US Patent and Trademark Office (USPTO) to collect demographic data from the patent applicants on a voluntary basis. The act is to ensure that patent rights are accessible and affordable to the minorities equally and to ensure that there is diversity within the applicant groups.
Read More at: https://www.ipwatchdog.com/2021/04/29/idea-act-passed-senate-judiciary-committee/id=132917/
Industry: Others
Petition Filed in Supreme Court of India to Direct Center to Issue Compulsory License for COVID-19 Drugs
shot by IP News Shots / 3:55 pm on 30 April, 2021
A petition has been filed with the Supreme Court of India by Jan Swasthya Abhiyan (JSA) of Mumbai to direct the Central Government of India to issue compulsory license for COVID-19 drugs. The petitioner, a network of members working towards health problems, has told the court that compulsory licensing will help the states in responding to the demand for COVID-19 drugs. The petition asserts that the lack of access to the drugs violates virus-affected people’s fundamental right to health.
Industry: Pharmaceuticals
EPO Chief Bats for Unitary Patents, Advises Quick Implementation
shot by IP News Shots / 7:29 pm on 22 April, 2021
The Chief of the European Patent Office (EPO) Antonio Campinos has urged the member states to speed up the process for the implementation of unitary patents. It has been asserted that the implementation of unitary patents offers better certainty in legal matters and leads to simpler administration and cost-effectiveness.
Read More at: https://www.intellectualpropertymagazine.com/patent/epo-president-calls-for-progress-on-unitary-patents-146560.htm
Industry: Others
Bipartisan Group Revives Bill Allowing Confidentiality of Patent Applicants During Examination Process
shot by IP News Shots / 5:10 pm on 11 March, 2021
A Bipartisan group of several US lawmakers have reintroduced a bill that enables the patent applicants to maintain confidentiality of their demographics, which would not be considered during the patent examination process. The bill aims to measure the patent diversity gap.
Read More at: https://www.law360.com/ip/articles/1363142/lawmakers-reintroduce-bill-to-quantify-patent-diversity-gap
Industry: Others